Fluconazole tablet
Pro Research Analysisby 
Searched over 200M research papers for "fluconazole tablet"
Fluconazole Tablets: Efficacy, Formulation, and Clinical Applications
Efficacy of Fluconazole Tablets in Treating Fungal Infections
Fluconazole, a bis-triazole antifungal drug, is widely used for treating various fungal infections due to its high water solubility, low plasma protein affinity, and metabolic stability. Clinical studies have demonstrated its effectiveness in treating esophageal candidiasis, oropharyngeal candidiasis, vulvovaginal candidiasis, and as a prophylactic treatment for invasive fungal diseases in immunocompromised patients.
Esophageal Candidiasis Treatment
A multicenter, randomized, double-blind study compared the efficacy of fluconazole tablets to itraconazole oral solution in treating esophageal candidiasis in immunocompromised patients. The study found that fluconazole had a clinical response rate of 91% and a mycologic eradication rate of 78%, making it a viable treatment option .
Oropharyngeal Candidiasis Treatment
In a pseudo-randomized clinical trial, fluconazole tablets were compared to in situ gels of fluconazole for treating oropharyngeal candidiasis. The study showed that fluconazole tablets had an 85% improvement rate in symptoms, although the in situ gel formulation showed a higher cure rate of 97% .
Vulvovaginal Candidiasis Treatment
Fluconazole tablets have been compared to other treatments for vulvovaginal candidiasis (VVC). A study comparing fluconazole to butoconazole nitrate vaginal cream found that fluconazole provided symptom relief within 22.9 hours, although butoconazole was faster at 17.5 hours . Another study comparing fluconazole to clotrimazole found that fluconazole had higher clinical and mycological cure rates at both short-term and long-term follow-ups .
Prophylaxis for Invasive Fungal Diseases
Fluconazole has also been evaluated for prophylactic use in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. A cost-effectiveness study found that fluconazole was a cost-effective alternative to posaconazole tablets, reducing the number of invasive fungal disease events and enhancing overall survival .
Formulation Development of Fluconazole Tablets
Lactose Agglomerate Tablets for Denture Disinfection
A study focused on developing fluconazole-loaded lactose agglomerate tablets for disinfecting Candida-associated dentures. The tablets, formulated using polyvinylpyrrolidone (PVP) as an agglomerating agent, showed excellent dispersibility and anticandidal efficiency, making them suitable for use as a disinfectant .
Mucoadhesive Vaginal Tablets
Fluconazole has also been formulated into mucoadhesive vaginal tablets to improve patient compliance and treatment efficacy. These tablets adhere to the mucous membrane, providing prolonged and sustained drug release. The formulation showed promising results in terms of hardness, friability, content uniformity, and mucoadhesive strength, making it a viable option for treating vaginal candidiasis .
Solid Dispersion for Enhanced Solubility
To address the poor solubility of fluconazole, a study employed a Quality by Design approach to develop a sustained-release vaginal tablet using solid dispersion. The optimized formulation showed improved drug release, bioadhesive strength, and antifungal activity against Candida albicans, suggesting its potential for effective treatment .
Conclusion
Fluconazole tablets are a versatile and effective treatment for various fungal infections, including esophageal, oropharyngeal, and vulvovaginal candidiasis. Advances in formulation, such as lactose agglomerate tablets and mucoadhesive vaginal tablets, have further enhanced their efficacy and patient compliance. Fluconazole remains a valuable antifungal agent with broad clinical applications.
Sources and full results
Most relevant research papers on this topic